Rite Aid's CEO, Jeffrey S. Stein, believes the MedImpact tra...
Rite Aid's CEO, Jeffrey S. Stein, believes the MedImpact transaction optimizes business value and prepares Elixir for future client support. He also mentioned progress with the court-supervised process and the Rite Aid 2.0 Plan.
Press Release: Rite Aid Receives Court Approval for Sale of Elixir Solutions Business to MedImpact
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4087Followers
0Following
9092Visitors
Follow